79 filings
Page 2 of 4
8-K
o69 vdbje
27 Sep 22
Other Events
5:00pm
8-K
2vtl5kjhao
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am
8-K
x60vqs8egwa6wd0
8 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:14pm
8-K
m49dpnom
5 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
tq61ir5y29g7l19tf
20 May 22
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
g6j6m
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
z9uzfp9hxop37jgwq
4 Apr 22
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
4:35pm
8-K
olj1ixvdioli
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
74rv15or9de1b07
21 Dec 21
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:03am
8-K
46oojn3jefjrux9xzs
15 Nov 21
Regulation FD Disclosure
11:32am
8-K
84ix8ralwan1ejg
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
gexcbr toshlk2b8dtk
3 Nov 21
PhaseBio Announces Topline Results from Phase 2b Trial for Bentracimab
8:04am
8-K
9siu 4hq05r
15 Sep 21
PhaseBio Appoints William D. Humphries to Board of Directors
8:04am
8-K
2uo7f7gybskpjk
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
rq62f21phjgv9l 9qcsj
10 Aug 21
PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab
8:03am
8-K
x9s5i7
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
y67iohn2
4 Jun 21
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
xj26z4rljrhslyj uc
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
8-K
lnwru5xacbkm7ws1
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
vox4 erpg48z
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am